Integrated Pharmacokinetic/Pharmacodynamic Model of a Bispecific CD3xCD123 DART Molecule in Nonhuman Primates: Evaluation of Activity and Impact of Immunogenicity von Campagne, Olivia, Delmas, Audrey, Fouliard, Sylvain, Chenel, Marylore, Chichili, Gurunadh R, Li, Hua, Alderson, Ralph, Scherrmann, Jean-Michel, Mager, Donald E

Volltext

Population Pharmacokinetics of Tacrolimus in Transplant Recipients: What Did We Learn About Sources of Interindividual Variabilities? von Campagne, Olivia, Mager, Donald E., Tornatore, Kathleen M.

Volltext

Tacrolimus Population Pharmacokinetics and Multiple CYP3A5 Genotypes in Black and White Renal Transplant Recipients von Campagne, Olivia, Mager, Donald E., Brazeau, Daniel, Venuto, Rocco C., Tornatore, Kathleen M.

Volltext

Population pharmacokinetic analysis of crizotinib in children with progressive/recurrent high-grade and diffuse intrinsic pontine gliomas von Gibson, Elizabeth G., Campagne, Olivia, Selvo, Nicholas S., Gajjar, Amar, Stewart, Clinton F.

Volltext

Population pharmacokinetics of crenolanib in children and young adults with brain tumors von Bisbee, Cora, Campagne, Olivia, Gajjar, Amar, Tinkle, Christopher L., Stewart, Clinton F.

Volltext

Development and Validation of a Sensitive and Specific LC-MS/MS Method for IWR-1-Endo, a Wnt Signaling Inhibitor: Application to a Cerebral Microdialysis Study von Nair, Sreenath, Davis, Abigail, Campagne, Olivia, Schuetz, John D, Stewart, Clinton F

Volltext

CNS penetration of methotrexate and its metabolite 7-hydroxymethotrexate in mice bearing orthotopic Group 3 medulloblastoma tumors and model-based simulations for children von Perkins, Rachel S., Davis, Abigail, Campagne, Olivia, Owens, Thandranese S., Stewart, Clinton F.

Volltext

Advancing clinical development for neuronopathic Hunter syndrome through a quantitatively‐driven reverse translation framework von Latzman, Robert D., Campagne, Olivia, Modi, Meera E., Karas, Marta, Malanga, C. J., Whiteman, David A. H.

Volltext

Correction to: Pharmacokinetics and safety of erlotinib and its metabolite OSI-420 in infants and children with primary brain tumors von Reddick, Samuel J., Campagne, Olivia, Huang, Jie, Onar-Thomas, Arzu, Broniscer, Alberto, Gajjar, Amar, Stewart, Clinton F.

Volltext

Pharmacokinetically guided dosing of oral sorafenib in pediatric hepatocellular carcinoma: A simulation study von Panetta, John C., Campagne, Olivia, Gartrell, Jessica, Furman, Wayne, Stewart, Clinton F.

Volltext

CNS Penetration of Cyclophosphamide and Metabolites in Mice Bearing Group 3 Medulloblastoma and Non-Tumor Bearing Mice von Stewart, Clinton, Campagne, Olivia, Davis, Abigail, Zhong, Bo, Nair, Sreenath, Haberman, Victoria, T Patel, Yogesh, Janke, Laura, F Roussel, Martine

Volltext

Evaluation of the performance of a prior tacrolimus population pharmacokinetic kidney transplant model among adult allogeneic hematopoietic stem cell transplant patients von Zhu, Jing, Campagne, Olivia, Torrice, Chad D., Flynn, Gabrielle, Miller, Jordan A., Patel, Tejendra, Suzuki, Oscar, Ptachcinski, Jonathan R., Armistead, Paul M., Wiltshire, Tim, Mager, Donald E., Weiner, Daniel L., Crona, Daniel J.

Volltext

Model‐based evaluation of image‐guided fractionated whole‐brain radiation therapy in pediatric diffuse intrinsic pontine glioma xenografts von Husband, Hillary R., Campagne, Olivia, He, Chen, Zhu, Xiaoyan, Bianski, Brandon M., Baker, Suzanne J., Shelat, Anang A., Tinkle, Christopher L., Stewart, Clinton F.

Volltext

Abstract 1358: Model-based evaluation of pegfilgrastim effects on chemotherapy-induced neutropenia in infants with CNS tumors von Campagne, Olivia, Davis, Abigail, Upadhyaya, Santhosh A., Stewart, Clinton F.

Volltext

Clinical Pharmacokinetics and Pharmacodynamics of Selumetinib von Campagne, Olivia, Yeo, Kee Kiat, Fangusaro, Jason, Stewart, Clinton F.

Volltext

Developing Therapy for Every Kid With Cancer – Summary of a Scientific Session at the 2023 ASCPT Meeting von Moore, Jason N., Campagne, Olivia, Bhojwani, Deepa, Crowe, Dean, Stewart, Clinton F.

Volltext

LC-MS/MS method for quantitation of the CK2 inhibitor silmitasertib (CX-4945) in human plasma, CSF, and brain tissue, and application to a clinical pharmacokinetic study in childre... von Zhong, Bo, Campagne, Olivia, Salloum, Ralph, Purzner, Teresa, Stewart, Clinton F.

Volltext

Abstract 1357: Population pharmacokinetic analysis of crizotinib in children with progressive/recurrent high-grade and diffuse intrinsic pontine gliomas von Gibson, Elizabeth Grace, Selvo, Nicholas S., Campagne, Olivia, Gajjar, Amar, Stewart, Clinton F.

Volltext

A phase II trial of selumetinib in children with recurrent optic pathway and hypothalamic low-grade glioma without NF1: a Pediatric Brain Tumor Consortium study von Fangusaro, Jason, Onar-Thomas, Arzu, Poussaint, Tina Young, Wu, Shengjie, Ligon, Azra H, Lindeman, Neal, Campagne, Olivia, Banerjee, Anu, Gururangan, Sridharan, Kilburn, Lindsay B, Goldman, Stewart, Qaddoumi, Ibrahim, Baxter, Patricia, Vezina, Gilbert, Bregman, Corey, Patay, Zoltan, Jones, Jeremy Y, Stewart, Clinton F, Fisher, Michael J, Doyle, Laurence Austin, Smith, Malcolm, Dunkel, Ira J, Fouladi, Maryam

Volltext

Abstract 3031: Characterization of gemcitabine triphosphate formation in mice to aid in the development of a translational tumor model von Gibson, Elizabeth G., Davis, Abi, Zhong, Bo, Campagne, Olivia, Roussel, Martine F., Stewart, Clinton F.

Volltext